What's new

Opinion/decision on a Paediatric investigation plan (PIP): Verzenios, abemaciclib, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Oncology, PIP number: P/0037/2024

Opinion/decision on a Paediatric investigation plan (PIP): Verzenios, abemaciclib, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Oncology, PIP number: P/0037/2024

Mar 24, 2025 - 17:08
 0
Opinion/decision on a Paediatric investigation plan (PIP): Verzenios, abemaciclib, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Oncology, PIP number: P/0037/2024
Opinion/decision on a Paediatric investigation plan (PIP): Verzenios, abemaciclib, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Oncology, PIP number: P/0037/2024
Read More

Tags:

Previous Article

Novo adds to obesity drug pipeline via $200M deal with China-based biotech

Next Article

FuelHub appoints new head of growth

Related Posts

Human medicines European public assessment report (EPAR): Pregabalin Sandoz, pregabalin, Date of authorisation: 19/06/2015, Revision: 21, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 19, 2025  0

Summary of opinion: Prevymis, 27/02/2025 Positive

Summary of opinion: Prevymis, 27/02/2025 Positive

Feb 28, 2025  0

Human medicines European public assessment report (EPAR): Trydonis, beclometasone,formoterol,glycopyrronium bromide, Date of authorisation: 26/04/2018, Revision: 8, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 17, 2025  0